Related Experiment Video
Updated: Aug 8, 2026

Using an Automated Cell Counter to Simplify Gene Expression Studies: siRNA Knockdown of IL-4 Dependent Gene Expression in Namalwa Cells
Published on: April 14, 2010
Modulation of the p27kip1 cyclin-dependent kinase inhibitor expression during IL-4-mediated human B cell activation
D A Blanchard1, M T Affredou, A Vazquez
1INSERM Unit 131-IPSC, Clamart, France.
Insights
Interleukin-4 (IL-4) and anti-IgM antibody together promote B cell proliferation by regulating cyclin D3/cdk6 complex formation and decreasing the p27 inhibitor. This dual action controls cell cycle progression in B cells.
Area of Science:
- Immunology
- Cell Biology
- Molecular Biology
Background:
- Interleukin-4 (IL-4) is known to activate B cells and, with co-stimulatory signals, modulate cell cycle progression leading to proliferation.
- Understanding the molecular mechanisms underlying IL-4-mediated B cell activation and proliferation is crucial for immunology and cancer research.
Purpose of the Study:
- To investigate the specific molecular events regulated by IL-4 during B cell activation and proliferation.
- To elucidate the roles of cyclin D3, cyclin-dependent kinase (cdk) 6, and the cdk inhibitor p27kip1 (p27) in IL-4-driven B cell cycle progression.
Main Methods:
- B cells were stimulated with IL-4 alone, anti-IgM antibody alone, or a combination of IL-4 and anti-IgM antibody.
- Expression levels of cyclin D3, cdk6, and p27 were analyzed.
- Cyclin D3/cdk6 complexes were immunoprecipitated and their kinase activity was assessed using recombinant retinoblastoma protein.
- IL-4's effect on proliferation inhibition in human leukemic B cells was studied in conjunction with p27 expression.
Main Results:
- The combination of IL-4 and anti-IgM antibody induced cyclin D3 and upregulated cdk6 expression in B cells.
- A functional cyclin D3/cdk6 complex was formed, capable of phosphorylating retinoblastoma protein.
- IL-4 or IL-13 alone increased p27 expression, while mitogenic combinations decreased it.
- IL-4-mediated inhibition of proliferation in leukemic B cells correlated with high p27 levels.
Conclusions:
- IL-4 controls B cell proliferation through at least two distinct mechanisms.
- These mechanisms involve the regulation of the cyclin D3/cdk6 complex and the expression of the p27 cdk inhibitor.
- These findings provide critical insights into the molecular regulation of B cell cycle progression by IL-4.
Abstract:
IL-4 activates resting B cells and, in conjunction with cosignals such as anti-IgM (anti-mu) Ab or CD40 ligand, modulates progression of B cells through the cell cycle, leading to proliferation. In this study, we show that the mitogenic combination of IL-4 and anti-mu Ab triggered induction of cyclin D3 and up-regulated cyclin-dependent kinase (cdk) 6 expression, whereas such regulation was not observed in B cells activated by IL-4 or anti-mu Ab alone. Furthermore, cyclin D3 immunoprecipitated fron as associated with cdk6, and the cyclin D3/cdk6 complex was able to phosphorylate recombinant retinoblastoma protein in vitro. In addition, B cells activated with either IL-4 or 1L-13 alone expressed a higher amount of p27kip1 (p27) cdk inhibitor than nonstimulated cells. In contrast, p27 expression was decreased when cells were activated with mitogenic combinations of IL-4 and anti-mu Ab or anti-CD40 mAb. We also observed that the IL-4-mediated inhibition of the proliferation of anti-mu/IL-2- or anti-mu/phorbol 12,13-dibutyrate-activated human leukemic B cells was associated with the maintenance of large amounts of p27 in these cells. These data suggest that IL-4 controls B cell proliferation by action during at least two steps of the regulation of the cell cycle, cyclin D3/cdk6 complex regulation and p27 inhibitor expression.
Related Concept Videos
Positive Regulator Molecules
Negative Regulator Molecules
Positive Regulator Molecules
Inhibition of Cdk Activity
Mitogens and the Cell Cycle
Abnormal Proliferation

